Targeting SIRT3 sensitizes glioblastoma to ferroptosis by promoting mitophagy and inhibiting SLC7A11

• Published in: Cell death & disease 2024-02, Vol.15 (2), p.168-168, Article 168
• Main Authors: Li, Xiaohe, Zhang, Wenlong, Xing, Zhengcao, Hu, Shuming, Zhang, Geqiang, Wang, Tiange, Wang, Tianshi, Fan, Qiuju, Chen, Guoqiang, Cheng, Jinke, Jiang, Xianguo, Cai, Rong
• Format: Article
• Language: English
• Subjects: 13/105; 13/31; 13/51; 13/89; 14/28; 38/39; 38/77; 631/67; 631/80/82; Amino Acid Transport System y+ - genetics; Antibodies; Biochemistry; Biomedical and Life Sciences; Brain cancer; Cell Biology; Cell Culture; Cell viability; Cystine; Ferroptosis; Ferroptosis - genetics; Glioblastoma; Glioblastoma - genetics; Glutathione; Humans; Immunology; Indans; Iron; Life Sciences; Mitochondria; Mitophagy; Sequence analysis; Sirtuin 3 - genetics
• ISSN: 2041-4889; 2041-4889
• DOI: 10.1038/s41419-024-06558-0

Glioblastoma (GBM) cells require large amounts of iron for tumor growth and progression, which makes these cells vulnerable to destruction via ferroptosis induction. Mitochondria are critical for iron metabolism and ferroptosis. Sirtuin-3 (SIRT3) is a deacetylase found in mitochondria that regulates mitochondrial quality and function. This study aimed to characterize SIRT3 expression and activity in GBM and investigate the potential therapeutic effects of targeting SIRT3 while also inducing ferroptosis in these cells. We first found that SIRT3 expression was higher in GBM tissues than in normal brain tissues and that SIRT3 protein expression was upregulated during RAS-selective lethal 3 (RSL3)-induced GBM cell ferroptosis. We then observed that inhibition of SIRT3 expression and activity in GBM cells sensitized GBM cells to RSL3-induced ferroptosis both in vitro and in vivo. Mechanistically, SIRT3 inhibition led to ferrous iron and ROS accumulation in the mitochondria, which triggered mitophagy. RNA-Sequencing analysis revealed that upon SIRT3 knockdown in GBM cells, the mitophagy pathway was upregulated and SLC7A11, a critical antagonist of ferroptosis via cellular import of cystine for glutathione (GSH) synthesis, was downregulated. Forced expression of SLC7A11 in GBM cells with SIRT3 knockdown restored cellular cystine uptake and consequently the cellular GSH level, thereby partially rescuing cell viability upon RSL3 treatment. Furthermore, in GBM cells, SIRT3 regulated SLC7A11 transcription through ATF4. Overall, our study results elucidated novel mechanisms underlying the ability of SIRT3 to protect GBM from ferroptosis and provided insight into a potential combinatorial approach of targeting SIRT3 and inducing ferroptosis for GBM treatment.